Moreno Jhenyffer Carvalho, Uson Junior Pedro Luiz Serrano
Universidade 9 de Julho, Sao Paulo 01509120, Brazil.
Center for Personalized Medicine, Hospital Israelita Albert Einstein, São Paulo 05652900, Brazil.
World J Clin Cases. 2024 Sep 6;12(25):5653-5656. doi: 10.12998/wjcc.v12.i25.5653.
Clear cell sarcoma (CCS) is a type of malignant tumor that can arise from tendons and aponeuroses. This malignant proliferation of cells with melanocytic lineage normally occurs in young patients, and it is normally identified in extremities. However, different sites including gastrointestinal organs are also described. Due difficulties in the molecular and histopathology evaluation, the diagnosis is often confused with malignant melanoma. Most cases are treated with surgical resection, but overall, the prognosis is poor. In this editorial, we will discuss a very interesting case of CCS identified in the pancreas. We will discuss the literature and controversies in the management of this type of cancer. Furthermore, we will address molecular strategies to be incorporated in those cases to better understand the primary location of the tumor. Finally, future perspectives of the field and new strategies of treatment will be described.
透明细胞肉瘤(CCS)是一种可起源于肌腱和腱膜的恶性肿瘤。这种具有黑素细胞谱系的细胞恶性增殖通常发生在年轻患者中,且通常在四肢被发现。然而,也有包括胃肠道器官在内的不同部位的报道。由于分子和组织病理学评估存在困难,诊断常与恶性黑色素瘤混淆。大多数病例采用手术切除治疗,但总体而言,预后较差。在这篇社论中,我们将讨论一例在胰腺中发现的非常有趣的CCS病例。我们将讨论这类癌症管理方面的文献及争议。此外,我们将探讨在这些病例中应采用的分子策略,以更好地了解肿瘤的原发部位。最后,将描述该领域的未来前景和新的治疗策略。